Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RadNet, Inc. filings document material-event disclosures for operating results, financial condition, governance, capital structure, and corporate actions tied to its diagnostic imaging and digital health businesses. Recent Form 8-K reports furnish quarterly results press releases and exhibits, including segment information for Imaging Centers and Digital Health.
The company’s proxy materials address board matters, executive compensation, and shareholder voting items. Other filings include leadership and compensatory-arrangement disclosures, prospectus supplements under automatic shelf registration statements for common stock resale registrations, and acquisition-related share issuance matters associated with RadNet’s health informatics expansion.
RadNet Inc. ownership filing: institutional investor T. Rowe Price Associates, Inc. reports beneficial ownership of 4,154,837 shares, equal to 5.4% of RadNet's common stock as of 03/31/2026. The filer discloses sole voting power for 4,130,454 shares and sole dispositive power for 4,154,837 shares.
The submission is a Schedule 13G ownership disclosure signed by a T. Rowe Price officer on 05/15/2026, with a statement disclaiming beneficial ownership in the filing text.
RadNet, Inc. reported first-quarter 2026 results showing strong top-line growth but continued losses as it invests heavily in expansion and AI. Total service revenue rose to $575.6 million from $471.4 million a year earlier, driven mainly by higher commercial insurance revenue and growth in Digital Health.
The company recorded a net loss attributable to common stockholders of $33.5 million, compared with $37.9 million in the prior-year quarter, or basic and diluted loss per share of $0.43. Operating cash flow improved to $79.0 million, while investing cash flows used $371.0 million, largely for acquisitions including the approximately $264.1 million purchase of AI firm Gleamer SAS.
Total assets reached $3.89 billion, including $1.09 billion of goodwill, and debt obligations stood at $1.09 billion. The company operated 435 imaging centers as of March 31, 2026 and continues to build out its Digital Health platform through acquisitions such as iCAD, See-Mode, CIMAR UK and Gleamer.
RadNet, Inc. reported record first quarter 2026 results, with Total Company Revenue of $575.6 million, a 22.1% increase from the first quarter of 2025, and Adjusted EBITDA of $63.3 million, up 36.3%. Growth was driven by advanced imaging volume, with MRI, CT and PET/CT procedures up 19.7% systemwide and same-center advanced imaging volumes up 8.2%.
The Digital Health segment generated revenue of $29.1 million, up 51.5%, while Adjusted EBITDA declined to $1.3 million due to intentional infrastructure investments. Annual Recurring Revenue for Digital Health rose to $96.9 million at March 31, 2026 from $49.8 million a year earlier.
RadNet still posted a net loss attributable to common stockholders of $33.5 million, or $(0.43) per share, improving from a $(0.51) loss per share a year ago. On an adjusted basis, diluted loss per share narrowed to $(0.28) from $(0.34). The company ended the quarter with $455.3 million in cash and a Net Debt to Adjusted EBITDA leverage ratio slightly below 2.0.
On the strategic side, RadNet closed the acquisition of Gleamer SAS to expand its DeepHealth AI portfolio and launched a new imaging joint venture with Trinity Health’s Saint Alphonsus Health System in Boise, Idaho. Reflecting strong trends, RadNet raised 2026 Imaging Center segment guidance, lifting revenue to $2,355–$2,405 million, Adjusted EBITDA to $340–$353 million, and Free Cash Flow to $112–$122 million, while reaffirming all Digital Health guidance ranges.
RadNet, Inc. President and CEO Howard G. Berger exercised stock options to acquire 25,992 shares of common stock at $18.64 per share. Following this transaction, he directly owns 498,405 common shares. An additional 20,000 shares are reported as indirectly owned through his spouse.
The exercised options relate to a previously granted award of 77,976 shares issued in connection with retention of employment. That award was subject to performance- and time-based vesting, with the performance condition for fiscal 2023 satisfied and the time-based vesting scheduled in three equal annual installments on March 10, 2025, 2026, and 2027.
RadNet Inc: Vanguard Portfolio Management reported beneficial ownership of 3,952,160 shares of Common Stock, representing 5.09% of the class as reported for the period ending 03/31/2026. The filing shows sole voting power for 53,033 shares and sole dispositive power for 3,952,160 shares.
RadNet, Inc. is asking stockholders to vote at its 2026 Annual Meeting on June 2, 2026 in Los Angeles. Proposals include electing six directors, ratifying Ernst & Young LLP as auditor for 2026, a non-binding say-on-pay vote, and approving an amended and restated Equity Incentive Plan.
The record date is April 6, 2026, with 78,271,515 common shares outstanding. RadNet reports 2025 revenue of $2.04 billion, up 11.5% from 2024, supported by nine new centers and 418 partnered centers. The company highlights ESG initiatives, a workforce of 8,844 full-time employees, and governance practices such as a majority-independent board, majority voting for uncontested director elections, and active stockholder engagement.
RadNet Inc ownership filing: The Vanguard Group reports 0 shares beneficially owned, representing 0% of Common Stock. The filing states an internal realignment effective January 12, 2026 that disaggregated certain Vanguard subsidiaries and business divisions, which now report separately in reliance on SEC Release No. 34-39538.
The filing is an amendment (Amendment No. 8) documenting that, after the reorganization, Vanguard entities reported here hold no voting or dispositive power over RadNet common shares.
RadNet, Inc. director and Chief Strategy Officer Alma Gregory Sorensen reported multiple transactions in the company’s common stock on March 19, 2026. She executed open‑market sales totaling 15,000 shares at prices reported around $61.84, $62.82, and $63.59, with footnotes noting sale price ranges between $61.38–$62.37 and $62.45–$63.44. She also transferred 7,000 shares as a bona fide charitable donation. Following these transactions, she directly holds 1,201,923 shares of RadNet common stock.
Alma Gregory Sorensen reported recent and proposed transactions in Common Stock. The filing lists sales of 15,000 shares on 03/18/2026 for $932,253.00 and 5,919 shares on 03/16/2026 for $365,335.47. The filing also lists restricted stock vesting entries of 9,756 shares on 03/10/2026, 4,877 shares on 06/01/2025, and 367 shares on 06/01/2022, described as "restricted stock vesting under a registered plan."